Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dopexamine: a new dopaminergic agonist]

G Perrin1, L Papazian, C Martin

  • 1Département d'Anesthésie-Réanimation, Hôpital Sainte-Marguerite, Marseille.

Annales Francaises D'Anesthesie Et De Reanimation
|January 1, 1993
PubMed
Summary

Dopexamine hydrochloride offers vasodilation and mild inotropic effects for low cardiac output states, presenting an alternative to dopamine with fewer side effects. Further trials are needed to define its therapeutic role.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Growth and morphogenesis in Streptomyces.

FEMS microbiology letters·1992
Same author

Malignant lymphoma in a patient with relapsing bronchiolitis obliterans organizing pneumonia.

Chest·1992
Same author

Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery.

Antimicrobial agents and chemotherapy·1992
Same author

Nucleotide sequence of the nfaA gene encoding the antigen 8786 adhesive factor of enterotoxigenic Escherichia coli.

FEMS microbiology letters·1992
Same author

Plant genetics flourishes.

Trends in genetics : TIG·1992
Same author

Relatedness of penicillin-binding protein 1a genes from different clones of penicillin-resistant Streptococcus pneumoniae isolated in South Africa and Spain.

The EMBO journal·1992

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Critical Care

Background:

  • Dopamine is commonly used for low cardiac output states but has drawbacks like vasoconstriction and arrhythmias.
  • Dopexamine hydrochloride is a synthetic catecholamine designed to address these limitations.
  • Understanding catecholamine receptor interactions is crucial for cardiovascular drug development.

Purpose of the Study:

  • To evaluate the hemodynamic effects and potential benefits of dopexamine hydrochloride.
  • To compare dopexamine hydrochloride's profile with existing treatments like dopamine.
  • To explore dopexamine hydrochloride's utility in various critical care scenarios.

Main Methods:

  • Review of dopexamine hydrochloride's pharmacological properties, including receptor activity.
  • Analysis of preliminary clinical data from studies in acute heart failure, post-cardiac surgery, and septic shock.
  • Assessment of hemodynamic changes such as cardiac index, heart rate, and vascular resistance.

Main Results:

  • Dopexamine hydrochloride exhibits significant vasodilation (beta-2 and dopaminergic activity) and mild inotropic effects.
  • It increases cerebral, myocardial, splanchnic, and renal blood flow, with associated diuresis and natriuresis.
  • Preliminary data suggest benefits in acute heart failure and septic shock, with a short half-life allowing rapid titration.

Conclusions:

  • Dopexamine hydrochloride improves cardiac performance through vasodilation and mild inotropy without increasing myocardial oxygen consumption.
  • Its unique receptor profile offers potential advantages over dopamine, particularly regarding vasodilation and reduced arrhythmogenic potential.
  • Comparative trials are essential to establish dopexamine hydrochloride's definitive place in therapy against dopamine and dobutamine.

Related Experiment Videos